A5012021692- Glioma Diagnosis and Treatment
- Neuroblastoma Research and Treatments
- Lung Cancer Research Studies
- Management of metastatic bone disease
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Prostate Cancer Treatment and Research
- Advanced MRI Techniques and Applications
- Surgical site infection prevention
- Transportation and Mobility Innovations
- Transportation Planning and Optimization
- Advanced Electron Microscopy Techniques and Applications
- Respiratory Support and Mechanisms
- Embedded Systems and FPGA Design
- Elevator Systems and Control
- Non-Invasive Vital Sign Monitoring
- Urban Transport and Accessibility
- Hemodynamic Monitoring and Therapy
- Brain Metastases and Treatment
- Industrial Automation and Control Systems
Zhejiang University
2023
First Affiliated Hospital Zhejiang University
2023
First Affiliated Hospital of Wannan Medical College
2021
Central South University
2018
Nanjing Tech University
2009
Abstract Purpose: Glioblastoma (GBM) is a highly vascularized tumor with few treatment options after disease recurrence. Here, we report the efficacy and safety of anlotinib hydrochloride plus temozolomide in patients recurrent GBM. Patients Methods: first definite postsurgical progression histologically confirmed GBM preceded by standard radiotherapy chemotherapy were eligible for inclusion. All received (150–200 mg/m2, orally, every day (QD) d1–5/4 wk) (10 mg, QD, d1–14/3 until or...
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>
<p>Supplementary figure 6. Wound dehiscence.</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced FLAIR MRI at pre-baseline (A-D). Three months later, demonstrated progressive disease after anlotinib plus temozolomide (E-H).</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced MRI at pre-baseline (A-C; yellow arrows), 6 months later demonstrating complete response after anlotinib plus temozolomide (E-G). Axial Fluid-Attenuated Inversion Recovery (FLAIR, D) image pre-baseline, no progression was observed during treatment (H).</p>
<div>Abstract<p>Background: Glioblastoma (GBM) is a highly vascularized tumor with few treatment options after disease recurrence. Here, we report the efficacy and safety of anlotinib hydrochloride plus temozolomide in patients recurrent GBM. Methods: Patients first definite postsurgical progression histologically confirmed GBM preceded by standard radiotherapy chemotherapy were eligible for inclusion. All received (150-200mg/m2, orally, QD, d1-5/4wks) (10mg, d1-14/3wks) until or...
<p>Supplementary figure 6. Wound dehiscence.</p>
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced FLAIR MRI at pre-baseline (A-D). Three months later, demonstrated progressive disease after anlotinib plus temozolomide (E-H).</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced MRI at pre-baseline (A-C; yellow arrows), 6 months later demonstrating complete response after anlotinib plus temozolomide (E-G). Axial Fluid-Attenuated Inversion Recovery (FLAIR, D) image pre-baseline, no progression was observed during treatment (H).</p>
Bus signal priority (BSP), as an important part of bus theories, aims at providing buses with more time resources. Previous studies indicated that BSP can effectively improve the operation without a significant negative effect on other vehicles. However, most them focus how to passing ability interactions and few consider role waiting passengers downstream stations. In view this, fuzzy-based model minimizing passenger wait Furthermore, influence vehicles is considered well. Simulation...
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>
<p>Supplementary figure 6. Wound dehiscence.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced MRI at pre-baseline (A-C; yellow arrows), 6 months later demonstrating complete response after anlotinib plus temozolomide (E-G). Axial Fluid-Attenuated Inversion Recovery (FLAIR, D) image pre-baseline, no progression was observed during treatment (H).</p>